An MRI-derived index of biological aging pace, originally developed in the Dunedin birth cohort, was tested in independent longitudinal samples and retained its association with the rate of age-related decline. The work supports the use of a single structural brain scan as a measure of how quickly an individual is aging, rather than how long they have lived.
Key Points
- Brain MRI aging-pace measure replicated in independent longitudinal cohorts
- Single structural scan estimates rate of decline, not chronological age
- Extension testing broadens applicability beyond the original birth cohort
Longevity Analysis
Measurement precedes meaningful intervention, and a validated neuroimaging marker of aging pace gives clinicians a quantitative signal where cognitive change is otherwise detected only after substantial loss. Brain tissue integrity reflects decades of cumulative vascular load, inflammatory burden, sleep quality, and metabolic control, which makes this index less a measure of the nervous system alone than a composite readout of how well the rest of the body has been maintained. Its practical value lies in repeated measurement over years, where a shifting trajectory can confirm whether sustained changes in behavior and exposure are altering the underlying rate of decline.
Original published by Nature - npj Aging, by Rebecca G. Reed.